Ist buxus sempervirens leaf extract in der Schwangerschaft sicher?
No EU restriction or ban listed for Buxus sempervirens extract in the EU cosmetics inventory (INCI entry present), and there are no SCCS or CIR safety assessments or harmonised CLP (Annex VI) CMR classifications identified for the cosmetic extract. Published toxicology about Buxus species reports steroidal alkaloids (e.g., cyclobuxine) that cause systemic toxicity after ingestion, but I did not find peer‑reviewed reproductive or developmental studies on the cosmetic leaf extract showing teratogenicity or reproductive effects; therefore hazard = 0 and mechanism = 0. Topical cosmetic exposure is expected to be low but measurable, so exposure = 1.
Related ingredients
Frequently asked questions
- Ist buxus sempervirens leaf extract in der Schwangerschaft sicher?
- No EU restriction or ban listed for Buxus sempervirens extract in the EU cosmetics inventory (INCI entry present), and there are no SCCS or CIR safety assessments or harmonised CLP (Annex VI) CMR classifications identified for the cosmetic extract. Published toxicology about Buxus species reports steroidal alkaloids (e.g., cyclobuxine) that cause systemic toxicity after ingestion, but I did not find peer‑reviewed reproductive or developmental studies on the cosmetic leaf extract showing teratogenicity or reproductive effects; therefore hazard = 0 and mechanism = 0. Topical cosmetic exposure is expected to be low but measurable, so exposure = 1.
- Ist buxus sempervirens leaf extract während des Stillens sicher?
- Same evidence base as for pregnancy: no regulatory bans/restrictions (EU Annex II/III), no harmonised H361/H360 classification, and no breastfeeding‑specific toxicity or transfer data for the cosmetic leaf extract. Ingestion of whole plant is known to be toxic (steroidal alkaloids), but that does not constitute evidence of reproductive/lactation hazard from topical cosmetic use; exposure from dermal use is low but measurable.
- Ist buxus sempervirens leaf extract sicher für Babyhaut?
- No infant‑specific reproductive or developmental toxicity data were identified for the cosmetic extract. Because infant skin has a higher surface‑area‑to‑body‑weight ratio and an immature barrier, I increased exposure by +1 relative to the adult dermal exposure score; there is still no evidence of a reproductive mechanism or harmonised classification for the cosmetic ingredient itself.
- Wie bewertet VeriMom buxus sempervirens leaf extract?
- VeriMom bewertet buxus sempervirens leaf extract mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu buxus sempervirens leaf extract?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu buxus sempervirens leaf extract basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.